80 likes | 313 Views
Respironics. Aaron Santavicca 10/16/2007. Vision. To be the worldwide leader at anticipating needs and providing valued solutions to the sleep and respiratory markets. Strategy Sales of products internationally
E N D
Respironics Aaron Santavicca 10/16/2007
Vision To be the worldwide leader at anticipating needs and providing valued solutions to the sleep and respiratory markets. Strategy • Sales of products internationally • Leverage and continue existing position as world-leader in OSA technology & sales • Introduction of new products, rather than improving existing ones
RESPIRONICS Sleep and Home Respiratory Group Hospital Group International Group Home Respiratory Care Children’s Medical Ventures (ChMV) • Germany • France • United Kingdom • Italy • Switzerland • Japan • China • . . . Sleep Disordered Breathing Critical Care Sleep Well Ventures Respiratory Drug Delivery (RDD)
Competitors • Respironics $1000 million • Invacare $141 million • ResMed Inc. $607 million • Restore Medical Inc. $5 million • Covidien(Tyco Healthcare) $1000 million (revenues from respiratory-related sales)
Major Issues and Competitive Forces • Anti-trust litigation from Invacare • New vs. Improved technology (the industry trend is towards improved) • International Exchange Rates
Industry Specific IS Needs • Supply Chain Management • Customer Relationship Management • Back-Office Information Management • Manufacturing Process Systems